Betts CD, D’Mellow MT, Fowler CJUrinary symptoms and the neurological features of bladder dysfunctions in multiple sclerosis. J Neurol Neurosurg Psychiatr1993; 56: 245-50.
2.
Wein AJDiagnosis and treatment of the overactive bladder. Urology2003; 62: 20-7.
3.
Ernst E., White ARProspective studies of the safety of acupuncture: a systematic review . Am J Med2001; 110: 481-5.
4.
Keppel Hesselink JM, Kopsky DJAcupuncture for bladder dysfunctions in multiple sclerosis. Med Acupunct2005; 17: 1-2.
5.
Vandoninck V. , van Balken MR, Finazzi Agro E., et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn2003; 22: 227-2.
6.
Wagner TH, Patrick DL, Bavendam TG, Martin ML, Buesching DPQuality of life of persons with urinary incontinence: development of a new measure. Urology1996; 47: 67-72.
7.
Chapple CR, Rechberger T., Al-Shukri S., et al. Randomized, double-blind placebo- and tolterodinecontrolled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int2004 ; 93: 303-10.